Ausgabe 6/2021
Inhalt (16 Artikel)
H2O2 enhances the anticancer activity of TMPyP4 by ROS-mediated mitochondrial dysfunction and DNA damage
Jianqiang Chen, Xiangxiang Jin, Zhe Shen, Yanan Mei, Jufan Zhu, Xiaodan Zhang, Guang Liang, Xiaohui Zheng
The anti-angiogenic agent lenvatinib induces tumor vessel normalization and enhances radiosensitivity in hepatocellular tumors
Norikazu Une, Mayumi Takano-Kasuya, Narufumi Kitamura, Mineto Ohta, Tomoya Inose, Chihiro Kato, Ryuichi Nishimura, Hiroshi Tada, Shigehito Miyagi, Takanori Ishida, Michiaki Unno, Takashi Kamei, Kohsuke Gonda
Treating MCF7 breast cancer cell with proteasome inhibitor Bortezomib restores apoptotic factors and sensitizes cell to Docetaxel
Kayhan Mehdizadeh, Farangis Ataei, Saman Hosseinkhani
Resistin increases cisplatin-induced cytotoxicity in lung adenocarcinoma A549 cells via a mitochondria-mediated pathway
Wei-Jing Gong, Tao Zhou, Jia-Qiang Xu, Yi-Fei Huang, Li-Ping Xiang, Fang Zeng, Yong Han, Yong-Ning Lv, Yu Zhang, San-Lan Wu
CDK2-instigates C/EBPα degradation through SKP2 in Acute myeloid leukemia
Gatha Thacker, Mukul Mishra, Akshay Sharma, Anil Kumar Singh, Sabyasachi Sanyal, Arun Kumar Trivedi
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance
Luca Triggiani, Rosario Mazzola, Davide Tomasini, Alessio Bruni, Giulia Alicino, Fabio Matrone, Roberto Bortolus, Giulio Francolini, Beatrice Detti, Alessandro Magli, Marco Lorenzo Bonù, Gianluca Ingrosso, Andrea Lancia, Fabio Trippa, Ernesto Maranzano, Ciro Franzese, Paolo Ghirardelli, Vittorio Vavassori, Marta Scorsetti, Filippo Alongi, Stefano Maria Magrini
The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas
Daniel Tesfa, Birgitta Sander, Henric Lindkvist, Christer Nilsson, Eva Kimby, Hans Hägglund, Björn E. Wahlin, Monika Klimkowska, Jan Palmblad
Preliminary evaluation on the beneficial effects of pioglitazone in the treatment of endometrial cancer
Garikapati Kusuma Kumari, Ammu V. V. V. Ravi Kiran, Praveen T. Krishnamurthy
The function of Cav-1 in MDA-MB-231 breast cancer cell migration and invasion induced by ectopic ATP5B
Xinjie Dong, Yilei Li, Wei Li, Wenzhe Kang, Rong Tang, Wenyi Wu, Ziyi Xing, Lijuan Zhou
PARP inhibitors: shifting the paradigm in the treatment of pancreatic cancer
Devashish Desai, Pushti Khandwala, Meghana Parsi, Rashmika Potdar
Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transition
Yaseen Hussain, Jing Hao Cui, Haroon Khan, Michael Aschner, Gaber El-Saber Batiha, Philippe Jeandet
Hypofractionated breast irradiation: a multidisciplinary review of the Senonetwork study group
Bruno Meduri, Fiorenza De Rose, Carlo Cabula, Isabella Castellano, Lucia Da Ros, Massimo Maria Grassi, Sandra Orrù, Fabio Puglisi, Rubina Manuela Trimboli, Antonella Ciabattoni
Novel therapeutic strategies and perspectives for pancreatic cancer: Autophagy and apoptosis are key mechanisms to fight pancreatic cancer
Wenhao Luo, Lianfang Zheng, Taiping Tai Zhang
The effect of the COVID-19 pandemic on routine adult vaccination in cancer patients
Nesligul Ozdemir, Aygin Bayraktar-Ekincioglu, Saadettin Kilickap